Sol J. Barer, Director at Aevi Genomic Medicine, Inc. (GNMX), bought 100,000 shares at $1.57 ($157K) on 2017-04-28, disclosed to the SEC on 2017-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| NEXI | BUY | 2022-06-02 | $312K | — | Filing → |
| NEXI | BUY | 2022-03-24 | $27K | — | Filing → |
| NEXI | BUY | 2022-03-23 | $72K | — | Filing → |